Search
for

    Sort by

    Research 271–300 of 281

    1. Beyond the Follicle: A Narrative Review on How Systemic Diseases and Drugs Affect Alopecia Pharmaceutical Medicine · 2026
    2. Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy Pharmaceuticals · 2025
    3. Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence Skin Appendage Disorders · 2025
    4. Breast cancer in a transgender man CA A Cancer Journal for Clinicians · 2025
    5. The potential use of phenolic compounds in the treatment of hair loss: a literature review Revista Brasileira de Plantas Medicinais · 2024
    6. Cytoprotective role of human dental pulp stem cell-conditioned medium in chemotherapy-induced alopecia Stem cell research & therapy · 2024
    7. Resfriamento de couro cabeludo para prevenção de alopecia induzida por quimioterapia: Estudo descritivo Concilium · 2022
    8. 55-Year-Old Female with Alopecia of the Scalp and Body After Chemotherapy Clinical Cases in Dermatology · 2022
    9. Determination of the Factors Affecting the Frequency and of Chemotherapy- Induced Alopecia and Methods of Coping with Alopecia Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · 2021
    10. Alopecia 2020
    11. Provenge is Talk of GU Malignancies Congress Oncology Times · 2010
    12. Dermatological adverse events with taxane chemotherapy European Journal of Dermatology · 2016 · 141 citations
    13. CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia EMBO Molecular Medicine · 2019 · 58 citations
    14. Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients Journal of The American Academy of Dermatology · 2017 · 31 citations
    15. Annurca Apple Polyphenols Protect Murine Hair Follicles from Taxane Induced Dystrophy and Hijacks Polyunsaturated Fatty Acid Metabolism toward β-Oxidation Nutrients · 2018 · 19 citations
    16. Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity Journal of Cancer · 2022 · 11 citations
    17. Low-Intensity Ultrasound as a Potential Intervention Strategy to Protect Human Scalp Hair Follicles from Taxane-Induced Toxicity Journal of Investigative Dermatology · 2023 · 7 citations
    18. Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex Journal of Clinical Oncology · 2005 · 5 citations
    19. Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies Cutis · 2021 · 2 citations
    20. Mechanism-Based Strategies for Prevention of Taxane-Induced Hair Follicle Damage in Cancer Chemotherapy Cancers · 2026
    21. 506 Taxane chemotherapy promotes aging of human hair follicles and their stem cells Journal of Investigative Dermatology · 2024
    22. 803 Taxane chemotherapy induces epigenetic changes and premature senescence in human scalp hair follicles Journal of Investigative Dermatology · 2024
    23. Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy Supportive care in cancer · 2017 · 11 citations
    24. Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer Cureus · 2018 · 3 citations
    25. 1400 Low-intensity ultrasound protects human scalp hair follicles from taxane-induced toxicity 2023
    26. Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results. Journal of clinical oncology · 2019
    27. Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey Supportive Care in Cancer · 2025 · 1 citations
    28. Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study BMC Cancer · 2024 · 5 citations
    29. Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study Drug Design Development and Therapy · 2025
    30. Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer Cancer Chemotherapy and Pharmacology · 2012 · 9 citations